Netherlands· NL-4270835006ac
Plegridy 125 microgram oplossing voor injectie in een voorgevulde spuit
A peginterferon beta-1a product containing peginterferon beta 1-a, registered in Netherlands by Biogen Netherlands B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Peginterferon beta-1a is registered in 14 of 19 countries.
Countries holding a registration under ATC L03AB13 (peginterferon beta-1a), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Peginterferon beta-1a · ATC L03AB13
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of peginterferon beta-1a costs, country by country.
Normalised to the WHO defined daily dose (8.9 mcg), the median price runs from $1.58 in Czechia to $45.18 in Switzerland — a ×29 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Peginterferon beta-1a · price per daily dose (8.9 mcg)
USD · FX 28 Sept 2026
- CH Switzerland$45.18
- CZ Czechia$1.58
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PEGINTERFERON BETA 1-A
- Manufacturer
- Biogen Netherlands B.V.
- Country
- Netherlands (NL)
- ATC code
- L03AB13
- ATC class
- Peginterferon beta-1a
- Defined daily dose
- 8.9 mcg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/14/934
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
338 interactions on record for peginterferon beta-1a.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Peginterferon beta-1a · interactions on record
338 records
- 15 severe
- 323 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- ZidovudineJ05AF01severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L03AB13
Peginterferon beta-1a, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5aaf54b-2183-46c0-8841-cee7769295c1 GET /v1/drugs/f5aaf54b-2183-46c0-8841-cee7769295c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/plegridy-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Peginterferon beta-1a",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp113843",
"excipients": [
"ARGININEHYDROCHLORIDE, (L-)",
"AZIJNZUUR (E 260), GECONCENTREERD",
"NATRIUMACETAAT 3-WATER (E 262)",
"POLYSORBAAT 20 (E 432)",
"WATER VOOR INJECTIE"
],
"substances": [
"PEGINTERFERON BETA 1-A"
],
"leaflet_url": null,
"authorised_at": "2014/07/18",
"procedure_number": "EMEA/H/C/002827",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/14/934",
"additional_monitoring": "N"
}See everything about peginterferon beta-1a.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.